Endovascular grafts for abdominal aortic aneurysm

Area of Science:

• Vascular Surgery
• Endovascular Interventions
• Aortic Aneurysm Management

Background:

• Endovascular technology has transformed abdominal aortic aneurysm (AAA) management over the past 20 years.
• Endovascular aortic repair (EVAR) is now the primary treatment for most AAA patients.
• Randomized controlled trials support AAA repair indications and EVAR use in select cases.

Purpose of the Study:

• To review current practices and evidence for endovascular aortic repair (EVAR) in abdominal aortic aneurysms (AAA).
• To identify areas requiring further research in AAA management.
• To discuss the evolving landscape of EVAR for AAA.

Main Methods:

• Review of current literature and evidence regarding EVAR for AAA.
• Analysis of randomized controlled trials and clinical practice variations.
• Discussion of ongoing technical and clinical developments in EVAR.

Main Results:

• EVAR is the treatment of choice for the majority of AAA patients.
• Practice patterns for EVAR vary, indicating a need for further clarification.
• Areas for future research include medical therapy, sex- and age-specific indications, and long-term follow-up for complex EVAR.

Conclusions:

• EVAR has revolutionized AAA treatment, offering robust evidence for selected patients.
• Further research is critical to address practice variations and optimize long-term outcomes for AAA patients undergoing EVAR.
• Continued technical and clinical advancements are anticipated in the field of EVAR for AAA.